NCT02918721View on ClinicalTrials.gov

Pain and Safety of Restylane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds

NACompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

April 27, 2017

Study Completion Date

May 11, 2017

Conditions

Nasolabial Fold

Interventions

DEVICE

Restylane Lidocaine

Intradermal injection

DEVICE

Restylane

Intradermal injection

Trial Locations (1)

Unknown

Q-Med AB, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY